Disease on EC 1.14.11.54 - mRNA N1-methyladenine demethylase
Please use the Disease Search for a specific query.
Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
Burkitt Lymphoma
Tp44 molecules involved in antigen-independent T cell activation are expressed on human plasma cells.
Carcinoma
Prostate cancer antigen-1 contributes to cell survival and invasion though discoidin receptor 1 in human prostate cancer.
Carcinoma
[Expression of prostate cancer antigen-1 in prostate cancer and its clinical significance]
Carcinoma, Hepatocellular
Association of AlkB homolog 3 expression with tumor recurrence and unfavorable prognosis in hepatocellular carcinoma.
Cerebellar Ataxia
Cerebrospinal fluid ?? T cell frequency is age-related: a case-control study of 435 children with inflammatory and non-inflammatory neurological disorders.
Digestive System Neoplasms
Emerging Roles of N6-Methyladenosine Demethylases and Its Interaction with Environmental Toxicants in Digestive System Cancers.
Down Syndrome
Purkinje cell cytoplasmic antibody type 1 (anti-yo) autoimmunity in a child with down syndrome.
Encephalitis
Cerebrospinal fluid ?? T cell frequency is age-related: a case-control study of 435 children with inflammatory and non-inflammatory neurological disorders.
Encephalomyelitis
Cerebrospinal fluid ?? T cell frequency is age-related: a case-control study of 435 children with inflammatory and non-inflammatory neurological disorders.
Encephalomyelitis, Acute Disseminated
Cerebrospinal fluid ?? T cell frequency is age-related: a case-control study of 435 children with inflammatory and non-inflammatory neurological disorders.
Lung Neoplasms
TP53 gene status is a critical determinant of phenotypes induced by ALKBH3 knockdown in non-small cell lung cancers.
Monoclonal Gammopathy of Undetermined Significance
Restricted expression of immunoglobulin light chain mRNA and of the adhesion molecule CD11b on circulating monoclonal B lineage cells in peripheral blood of myeloma patients.
Monoclonal Gammopathy of Undetermined Significance
Selective expression of CD45 isoforms defines CALLA+ monoclonal B-lineage cells in peripheral blood from myeloma patients as late stage B cells.
Multiple Myeloma
Elimination of myeloma cells from bone marrow by using monoclonal antibodies and magnetic immunobeads.
Multiple Myeloma
Restricted expression of immunoglobulin light chain mRNA and of the adhesion molecule CD11b on circulating monoclonal B lineage cells in peripheral blood of myeloma patients.
Multiple Myeloma
Selective expression of CD45 isoforms defines CALLA+ monoclonal B-lineage cells in peripheral blood from myeloma patients as late stage B cells.
Neoplasms
Anti-yo associated paraneoplastic cerebellar degeneration in a man with large cell cancer of the lung.
Neoplasms
Association of AlkB homolog 3 expression with tumor recurrence and unfavorable prognosis in hepatocellular carcinoma.
Neoplasms
Design and synthesis of prostate cancer antigen-1 (PCA-1/ALKBH3) inhibitors as anti-prostate cancer drugs.
Neoplasms
Elimination of myeloma cells from bone marrow by using monoclonal antibodies and magnetic immunobeads.
Neoplasms
Emerging Roles of N6-Methyladenosine Demethylases and Its Interaction with Environmental Toxicants in Digestive System Cancers.
Neoplasms
Paraneoplastic Cerebellar Degeneration (PCD) associated with PCA-1 antibodies in established cancer patients.
Neoplasms
Paraneoplastic gastrointestinal motor dysfunction: clinical and laboratory characteristics.
Neoplasms
Prostate cancer antigen-1 contributes to cell survival and invasion though discoidin receptor 1 in human prostate cancer.
Neoplasms
Proteins of human urine. II. Identification by two-dimensional electrophoresis of a new candidate marker for prostatic cancer.
Neoplasms
[Expression of prostate cancer antigen-1 in prostate cancer and its clinical significance]
Neoplasms, Second Primary
Paraneoplastic Cerebellar Degeneration (PCD) associated with PCA-1 antibodies in established cancer patients.
Nervous System Diseases
Purkinje cell cytoplasmic antibody type 1 (anti-yo) autoimmunity in a child with down syndrome.
Ovarian Neoplasms
Paraneoplastic Cerebellar Degeneration (PCD) associated with PCA-1 antibodies in established cancer patients.
Paraneoplastic Cerebellar Degeneration
Paraneoplastic Cerebellar Degeneration (PCD) associated with PCA-1 antibodies in established cancer patients.
Paraneoplastic Syndromes
Paraneoplastic Cerebellar Degeneration (PCD) associated with PCA-1 antibodies in established cancer patients.
Paraproteinemias
Restricted expression of immunoglobulin light chain mRNA and of the adhesion molecule CD11b on circulating monoclonal B lineage cells in peripheral blood of myeloma patients.
Paraproteinemias
Selective expression of CD45 isoforms defines CALLA+ monoclonal B-lineage cells in peripheral blood from myeloma patients as late stage B cells.
Plasmacytoma
Studies of in vitro activation and differentiation of human B lymphocytes. I. Phenotypic and functional characterization of the B cell population responding to anti-Ig antibody.
Pleural Effusion
Establishment of a monoclonal antibody to plasma cells: a comparison with CD38 and PCA-1.
Prostatic Hyperplasia
Anti-Tumor Effect of AlkB Homolog 3 Knockdown in Hormone- Independent Prostate Cancer Cells.
Prostatic Hyperplasia
Proteins of human urine. II. Identification by two-dimensional electrophoresis of a new candidate marker for prostatic cancer.
Prostatic Intraepithelial Neoplasia
High expression of a new marker PCA-1 in human prostate carcinoma.
Prostatic Intraepithelial Neoplasia
Prostate cancer antigen-1 as a potential novel marker for prostate cancer.
Prostatic Intraepithelial Neoplasia
[Expression of prostate cancer antigen-1 in prostate cancer and its clinical significance]
Prostatic Neoplasms
Anti-Tumor Effect of AlkB Homolog 3 Knockdown in Hormone- Independent Prostate Cancer Cells.
Prostatic Neoplasms
Clinical significance and therapeutic potential of prostate cancer antigen-1/ALKBH3 in human renal cell carcinoma.
Prostatic Neoplasms
Design and synthesis of prostate cancer antigen-1 (PCA-1/ALKBH3) inhibitors as anti-prostate cancer drugs.
Prostatic Neoplasms
Improving the bioavailability and anticancer effect of the PCA-1/ALKBH3 inhibitor HUHS015 using sodium salt.
Prostatic Neoplasms
Novel Metabolically Stable PCA-1/ALKBH3 Inhibitor Has Potent Antiproliferative Effects on DU145 Cells
Prostatic Neoplasms
Prostate cancer antigen-1 as a potential novel marker for prostate cancer.
Prostatic Neoplasms
Prostate cancer antigen-1 contributes to cell survival and invasion though discoidin receptor 1 in human prostate cancer.
Prostatic Neoplasms
[Effect of downregulation of prostate cancer antigen-1 expression on malignant biological behavior of prostate cancer LNCaP cells].
Prostatic Neoplasms
[Expression of prostate cancer antigen-1 in prostate cancer and its clinical significance]
html completed